Investigation of a New Compression Bandage System Combining Skin Protection, Padding and Compression in One Single Bandage and Comparing to an Existing One-component Bandage.

Inclusion criteria

• Healthy intact skin with no clinical signs of chronic venous insufficiency and no signs of any dermatological condition such as eczema or psoriasis as assessed by investigating physician.
• Ankle circumference > 18 cm (2 cm above ankle) as assessed by the investigating physician.

Exclusion criteria

• Known sensitivity to the study products (Rosidal 1C or Urgo K1) or any of their components
• Chronic venous disease with CEAP ≥2
• Ankle Brachial Pressure Index (ABPI) < 0.8 or >1.3
• Ankle circumference <18 or > 32 cm
• Venous echo-Doppler with recognizable abnormalities
• History of

• malignant ulcer
• clinically infected wound
• peripheral arterial occlusive diseases,
• cardiac insufficiency or cardiac disease such as congestive heart failure, coronary artery disease, myocardial infarction, coronary artery bypass graft
• cerebrovascular disease
• liver or renal disease
• septic phlebitis,
• phlegmasia coerulea dolens,
• sensation disorders of the skin
• eczema, psoriasis
• Use of diuretics, antihypertension or drugs that influence the capillary infiltration
• Comorbidities that could affect compression therapy, particularly diseases causing oedema
• Reliable severe malnutrition
• Diabetes Mellitus
• BMI > 30 kg/m2
• Pregnancy or breast feeding
• Participation in an interventional clinical trial within the last 3 months and during participation in this study
• Participant is analphabet